1-4 of 4
Thomas Weimer
Close
Sort by
Journal Articles

Pharmacokinetic Properties of Different rFVIII Products in Rabbits, Rats and FVIII Ko Mice

Sabine Pestel, DVM, Philipp Claar, Dr rer nat, Jochen Müller-Cohrs, Dr rer nat, Elmar Raquet, Hendrik Peil, Thomas Weimer, Dr rer nat, Eva Herzog, PhD
Journal: Blood
Blood (2015) 126 (23): 1078.
https://doi.org/10.1182/blood.V126.23.1078.1078
Published: 2015
Journal Articles

Pre-Clinical Characteristics of a Recombinant Fusion Protein Linking Activated Coagulation Factor VII with Albumin (rVIIa-FP)

Sabine Zollner, Daniel Schuermann, Elmar Raquet, Jochen Mueller-Cohrs, Thomas Weimer, Ingo Pragst, Gerhard Dickneite, Prof. PhD, Stefan Schulte, PhD
Journal: Blood
Blood (2012) 120 (21): 1115.
https://doi.org/10.1182/blood.V120.21.1115.1115
Published: 2012
Journal Articles

Prolonged In-Vivo Half-Life of FVIIa by Fusion to Albumin.

Stefan Schulte, PhD, Thomas Weimer, PhD, Wilfried Wormsbaecher, Ulrich Kronthaler, PhD, Albrecht Groener, PhD, Wiegand Lang, Uwe Liebing
Journal: Blood
Blood (2007) 110 (11): 3142.
https://doi.org/10.1182/blood.V110.11.3142.3142
Published: 2007
Journal Articles

Generation of Factor VIII Molecules Partially Resistant to Activated Protein C.

Veronique Rolli, Ph D, Nathalie Enjolras, PhD, Cecile Ducasse, Marie-Helene Rodriguez, PhD, Thomas Weimer, PhD, Hans-Peter Hauser, PhD, Claude Negrier, MD, PhD, Jean-Luc Plantier, Ph D
Journal: Blood
Blood (2004) 104 (11): 1729.
https://doi.org/10.1182/blood.V104.11.1729.1729
Published: 2004